vs
Blink Charging Co.（BLNK）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
REGENXBIO Inc.的季度营收约是Blink Charging Co.的1.1倍（$30.3M vs $27.0M），Blink Charging Co.净利率更高（-113.3% vs -221.3%，领先108.1%），REGENXBIO Inc.同比增速更快（43.0% vs -3.5%），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs -15.2%）
Blink Charging Co.是总部位于美国马里兰州鲍伊市的电动汽车充电网络运营商，是美国三大电动汽车充电网络服务商之一，业务遍及全球25个国家，共运营超过九万个充电桩。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
BLNK vs RGNX — 直观对比
营收规模更大
RGNX
是对方的1.1倍
$27.0M
营收增速更快
RGNX
高出46.5%
-3.5%
净利率更高
BLNK
高出108.1%
-221.3%
两年增速更快
RGNX
近两年复合增速
-15.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $27.0M | $30.3M |
| 净利润 | $-30.6M | $-67.1M |
| 毛利率 | 15.8% | — |
| 营业利润率 | -120.9% | -190.0% |
| 净利率 | -113.3% | -221.3% |
| 营收同比 | -3.5% | 43.0% |
| 净利润同比 | 60.1% | -31.2% |
| 每股收益（稀释后） | $-0.27 | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLNKRGNX
| Q4 25 | $27.0M | $30.3M | ||
| Q3 25 | $27.1M | $29.7M | ||
| Q2 25 | $28.7M | $21.4M | ||
| Q1 25 | $20.7M | $89.0M | ||
| Q4 24 | $28.0M | $21.2M | ||
| Q3 24 | $25.2M | $24.2M | ||
| Q2 24 | $33.3M | $22.3M | ||
| Q1 24 | $37.6M | $15.6M |
净利润BLNKRGNX
| Q4 25 | $-30.6M | $-67.1M | ||
| Q3 25 | $-86.0K | $-61.9M | ||
| Q2 25 | $-32.0M | $-70.9M | ||
| Q1 25 | $-20.7M | $6.1M | ||
| Q4 24 | $-76.7M | $-51.2M | ||
| Q3 24 | $-87.4M | $-59.6M | ||
| Q2 24 | $-20.1M | $-53.0M | ||
| Q1 24 | $-17.2M | $-63.3M |
毛利率BLNKRGNX
| Q4 25 | 15.8% | — | ||
| Q3 25 | 34.5% | — | ||
| Q2 25 | 16.8% | — | ||
| Q1 25 | 34.1% | — | ||
| Q4 24 | 15.7% | 70.2% | ||
| Q3 24 | 36.2% | 48.8% | ||
| Q2 24 | 32.2% | 52.5% | ||
| Q1 24 | 35.7% | 72.6% |
营业利润率BLNKRGNX
| Q4 25 | -120.9% | -190.0% | ||
| Q3 25 | -1.7% | -176.3% | ||
| Q2 25 | -103.0% | -296.3% | ||
| Q1 25 | -103.2% | 13.6% | ||
| Q4 24 | -274.2% | -242.1% | ||
| Q3 24 | -350.3% | -256.6% | ||
| Q2 24 | -62.1% | -251.3% | ||
| Q1 24 | -46.5% | -408.8% |
净利率BLNKRGNX
| Q4 25 | -113.3% | -221.3% | ||
| Q3 25 | -0.3% | -208.3% | ||
| Q2 25 | -111.3% | -331.8% | ||
| Q1 25 | -99.9% | 6.8% | ||
| Q4 24 | -273.7% | -241.3% | ||
| Q3 24 | -347.0% | -246.3% | ||
| Q2 24 | -60.3% | -237.7% | ||
| Q1 24 | -45.7% | -405.4% |
每股收益（稀释后）BLNKRGNX
| Q4 25 | $-0.27 | $-1.30 | ||
| Q3 25 | $0.00 | $-1.20 | ||
| Q2 25 | $-0.28 | $-1.38 | ||
| Q1 25 | $-0.21 | $0.12 | ||
| Q4 24 | $-0.77 | $-0.99 | ||
| Q3 24 | $-0.86 | $-1.17 | ||
| Q2 24 | $-0.20 | $-1.05 | ||
| Q1 24 | $-0.17 | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.6M | $230.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $64.5M | $102.7M |
| 总资产 | $147.5M | $453.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLNKRGNX
| Q4 25 | $39.6M | $230.1M | ||
| Q3 25 | $23.1M | $274.2M | ||
| Q2 25 | $25.3M | $323.3M | ||
| Q1 25 | $42.0M | $267.9M | ||
| Q4 24 | $55.4M | $234.7M | ||
| Q3 24 | $64.6M | $255.5M | ||
| Q2 24 | $73.9M | $290.4M | ||
| Q1 24 | $93.5M | $338.7M |
股东权益BLNKRGNX
| Q4 25 | $64.5M | $102.7M | ||
| Q3 25 | $90.8M | $161.5M | ||
| Q2 25 | $70.8M | $213.7M | ||
| Q1 25 | $102.6M | $274.2M | ||
| Q4 24 | $115.5M | $259.7M | ||
| Q3 24 | $194.5M | $301.4M | ||
| Q2 24 | $278.4M | $348.3M | ||
| Q1 24 | $296.7M | $390.7M |
总资产BLNKRGNX
| Q4 25 | $147.5M | $453.0M | ||
| Q3 25 | $171.3M | $525.2M | ||
| Q2 25 | $168.4M | $581.0M | ||
| Q1 25 | $199.1M | $490.9M | ||
| Q4 24 | $215.0M | $466.0M | ||
| Q3 24 | $303.0M | $519.1M | ||
| Q2 24 | $380.3M | $569.4M | ||
| Q1 24 | $404.5M | $629.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $683.0K | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-52.8M |
| 自由现金流率自由现金流/营收 | — | -174.0% |
| 资本支出强度资本支出/营收 | — | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-126.4M |
8季度趋势，按日历期对齐
经营现金流BLNKRGNX
| Q4 25 | $683.0K | $-52.3M | ||
| Q3 25 | $-3.0M | $-56.0M | ||
| Q2 25 | $-16.7M | $-49.3M | ||
| Q1 25 | $-11.9M | $33.6M | ||
| Q4 24 | $-13.5M | $-31.6M | ||
| Q3 24 | $-9.1M | $-40.5M | ||
| Q2 24 | $-4.3M | $-45.5M | ||
| Q1 24 | $-21.5M | $-55.5M |
自由现金流BLNKRGNX
| Q4 25 | — | $-52.8M | ||
| Q3 25 | $-4.9M | $-56.5M | ||
| Q2 25 | — | $-49.7M | ||
| Q1 25 | $-14.2M | $32.6M | ||
| Q4 24 | $-14.4M | $-32.7M | ||
| Q3 24 | $-10.1M | $-40.9M | ||
| Q2 24 | $-10.0M | $-46.0M | ||
| Q1 24 | $-24.3M | $-56.0M |
自由现金流率BLNKRGNX
| Q4 25 | — | -174.0% | ||
| Q3 25 | -18.0% | -189.9% | ||
| Q2 25 | — | -232.8% | ||
| Q1 25 | -68.6% | 36.6% | ||
| Q4 24 | -51.5% | -154.2% | ||
| Q3 24 | -40.1% | -168.9% | ||
| Q2 24 | -30.1% | -206.2% | ||
| Q1 24 | -64.7% | -358.5% |
资本支出强度BLNKRGNX
| Q4 25 | — | 1.7% | ||
| Q3 25 | 6.9% | 1.7% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | 11.4% | 1.2% | ||
| Q4 24 | 3.4% | 5.1% | ||
| Q3 24 | 3.9% | 1.3% | ||
| Q2 24 | 17.3% | 2.1% | ||
| Q1 24 | 7.5% | 3.6% |
现金转化率BLNKRGNX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLNK
| Products | $11.0M | 41% |
| Host Provider Fees | $5.9M | 22% |
| Network | $3.7M | 14% |
| Transferred Over Time | $3.2M | 12% |
| Network Fees And Warranty Contracts | $1.6M | 6% |
| Car Sharing Services | $1.3M | 5% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
